{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:33:06Z","timestamp":1793370786040,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clinbiochem.2026.111149","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:47:10Z","timestamp":1781459230000},"page":"111149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Establishment of PCOS-specific prolactin reference intervals to optimize laboratory demand management for macroprolactin screening"],"prefix":"10.1016","volume":"144","author":[{"given":"Sanz-Felisi","family":"Mar\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dur\u00e1n-Esp\u00edn","family":"Sof\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tauler-Quetglas","family":"Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al\u00eda-Ramos","family":"Pedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fern\u00e1ndez-Cid\u00f3n","family":"B\u00e1rbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2026.111149_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0010","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0015","first-page":"59","article-title":"International evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"69","author":"Teede","year":"2023","journal-title":"Monash University"},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/1179558119871921","article-title":"PCOS and hyperprolactinemia: what do we know in 2019?","volume":"13","author":"Delcour","year":"2019","journal-title":"Clin Med Insights Reprod Health."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120277","article-title":"Prolactin as a novel biomarker in malignancy","volume":"572","author":"Safdari","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/cen.15101","article-title":"Biomarkers to inform the management of polycystic ovary syndrome: a review of systematic reviews","volume":"101","author":"Walford","year":"2024","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0040","first-page":"725","article-title":"Determination of prolactin: the macroprolactin problem","volume":"27","author":"Fahie-Wilson","year":"2013","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0045","doi-asserted-by":"crossref","first-page":"020351","DOI":"10.11613\/BM.2019.020706","article-title":"Optimizing laboratory defined macroprolactin algorithm","volume":"29","author":"\u0160ostari\u0107","year":"2019","journal-title":"Biochem. Med."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.xfre.2023.05.005","article-title":"Macroprolactinemia: a mini-review and update on clinical practice","volume":"4","author":"Koniares","year":"2023","journal-title":"F&S Rep."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0055","first-page":"161","article-title":"Macroprolactin; a frequent cause of misdiagnosed hyperprolactinemia in clinical practice","volume":"11","author":"Richa","year":"2010","journal-title":"J Reprod Infertil."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0060","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.tjog.2017.10.002","article-title":"Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia","volume":"56","author":"Kasum","year":"2017","journal-title":"Taiwan J Obstetr Gynecol."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0065","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1373\/clinchem.2005.065854","article-title":"Specificity and clinical utility of methods for the detection of macroprolactin","volume":"52","author":"Kavanagh","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111149_bb0075","first-page":"63","article-title":"Macroprolactin: from laboratory to clinical practice","volume":"69","author":"Biagetti","year":"2022","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0080","series-title":"Clinical and Laboratory Standards Institute (CLSI). Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory","year":"2013"},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111149_bb0085","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jc.2011-3362","article-title":"Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging","volume":"97","author":"Harlow","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111149_bb0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1515\/cclm-2016-1112","article-title":"Critical comments to a recent EFLM recommendation for the review of reference intervals","volume":"55","author":"Haeckel","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.advms.2021.12.003","article-title":"To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study","volume":"67","author":"Mahboobifard","year":"2022","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0100","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/aogs.12247","article-title":"Elevated serum levels of anti-M\u00fcllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome","volume":"92","author":"Sahmay","year":"2013","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0105","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1080\/01443615.2019.1587604","article-title":"AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome","volume":"39","author":"Calzada","year":"2019","journal-title":"J Obstet Gynecol."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0110","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.31083\/j.ceog4805184","article-title":"Are plasma brain-derived neurotrophic factor or reproductive hormones related to depression in PCOS patients?: a prospective cohort study","volume":"48","author":"Kim","year":"2021","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0115","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.3390\/diagnostics12122924","article-title":"A meta-analysis of observational studies on prolactin levels in women with polycystic ovary syndrome","volume":"12","author":"Saei Ghare Naz","year":"2022","journal-title":"Diagn"},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0120","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a pituitary society international consensus statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2265.2001.01190.x","article-title":"The effect of the menopause on prolactin levels in patients with hyperprolactinaemia","volume":"54","author":"Karunakaran","year":"2001","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.14341\/probl13095","article-title":"Determination of prolactin reference intervals in different age groups","volume":"69","author":"Kolesnikova","year":"2023","journal-title":"Probl Endocrinol."},{"key":"10.1016\/j.clinbiochem.2026.111149_bb0135","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s11154-024-09927-4","article-title":"Reference intervals for serum prolactin concentrations: analytical and clinical considerations","volume":"25","author":"Coleman","year":"2024","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"11","key":"10.1016\/j.clinbiochem.2026.111149_bb0140","first-page":"2124","article-title":"Prolactin in polycystic ovary syndrome: metabolic effects and therapeutic prospects","volume":"13","author":"Mastnak","year":"2023","journal-title":"Life (Basel)."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:54:26Z","timestamp":1793368466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912026000779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"alternative-id":["S0009912026000779"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111149","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of PCOS-specific prolactin reference intervals to optimize laboratory demand management for macroprolactin screening","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111149"}}